76 related articles for article (PubMed ID: 1441834)
1. DNA-platinum-DNA cross-links formation induced by cis and trans-diamminedichloroplatinum in isolated leukocyte nuclei.
Walter Z; Spychała M
Acta Biochim Pol; 1992; 39(1):45-8. PubMed ID: 1441834
[No Abstract] [Full Text] [Related]
2. Interstrand DNA-platinum-DNA/cross-links induced by cis- and trans-diamminedichloroplatinum(II) at elevated temperature.
Kulamowicz I; Walter Z; Krupa R
Acta Biochim Pol; 1990; 37(1):77-9. PubMed ID: 2087920
[TBL] [Abstract][Full Text] [Related]
3. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
Plooy AC; van Dijk M; Lohman PH
Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808
[TBL] [Abstract][Full Text] [Related]
4. The effect of cis-diamminedichloroplatinum (II) on the formation of DNA-Pt-DNA cross-links.
Walter Z; Spychała M
Acta Biochim Pol; 1991; 38(1):95-9. PubMed ID: 1796714
[TBL] [Abstract][Full Text] [Related]
5. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
Roberts JJ; Friedlos F
Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
[TBL] [Abstract][Full Text] [Related]
6. Endogenous degradation of DNA and chromatin in rat liver nuclei after in vivo treatment with cis- and trans-diamminedichloroplatinum (II).
Ganeva R; Kokileva L
Cytobios; 1990; 62(250-251):167-74. PubMed ID: 2171880
[TBL] [Abstract][Full Text] [Related]
7. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
8. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).
Plooy AC; van Dijk M; Berends F; Lohman PH
Cancer Res; 1985 Sep; 45(9):4178-84. PubMed ID: 3928152
[TBL] [Abstract][Full Text] [Related]
9. DNA adducts of cisplatin, transplatin and platinum-intercalating drugs.
Leng M; Brabec V
IARC Sci Publ; 1994; (125):339-48. PubMed ID: 7806323
[No Abstract] [Full Text] [Related]
10. In vivo DNA-protein cross-linking by cis- and trans-diamminedichloroplatinum(II).
Olinski R; Wedrychowski A; Schmidt WN; Briggs RC; Hnilica LS
Cancer Res; 1987 Jan; 47(1):201-5. PubMed ID: 2431763
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.
Evans DL; Tilby M; Dive C
Cancer Res; 1994 Mar; 54(6):1596-603. PubMed ID: 8137265
[TBL] [Abstract][Full Text] [Related]
12. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
14. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II).
Fichtinger-Schepman AM; van Oosterom AT; Lohman PH; Berends F
Cancer Res; 1987 Jun; 47(11):3000-4. PubMed ID: 3552211
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteins of chicken liver nuclei cross-linked to DNA by cis-diamminedichloroplatinum.
Krześlak A; Lipińska A
Gen Physiol Biophys; 2002 Sep; 21(3):267-76. PubMed ID: 12537351
[TBL] [Abstract][Full Text] [Related]
16. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms.
Marples B; Adomat H; Billings PC; Farrell NP; Koch CJ; Skov KA
Anticancer Drug Des; 1994 Oct; 9(5):389-99. PubMed ID: 7945723
[TBL] [Abstract][Full Text] [Related]
17. Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts.
Whitehead JP; Lippard SJ
Met Ions Biol Syst; 1996; 32():687-726. PubMed ID: 8640535
[No Abstract] [Full Text] [Related]
18. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.
Bungo M; Fujiwara Y; Kasahara K; Nakagawa K; Ohe Y; Sasaki Y; Irino S; Saijo N
Cancer Res; 1990 May; 50(9):2549-53. PubMed ID: 2158392
[TBL] [Abstract][Full Text] [Related]
19. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
Chao CC
Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407
[TBL] [Abstract][Full Text] [Related]
20. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
Shellard SA; Hosking LK; Hill BT
Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
